Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatitis C
|
347 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.100 | 0.965 | 113 | 2010 | 2019 | |||||
Hepatitis C, Chronic
|
80 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.900 | 1.000 | 18 | 2009 | 2019 | |||||
Pseudohyperkalemia Cardiff
|
60 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.100 | 0.933 | 15 | 2011 | 2019 | |||||
Liver carcinoma
|
942 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.090 | 0.889 | 9 | 2012 | 2019 | |||||
Hepatitis B
|
519 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.080 | 0.750 | 8 | 2011 | 2017 | |||||
Fibrosis, Liver
|
64 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.070 | 1.000 | 7 | 2010 | 2019 | |||||
Liver diseases
|
100 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.060 | 1.000 | 6 | 2011 | 2017 | |||||
Complete atrioventricular block
|
96 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Fatty Liver
|
35 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Liver Cirrhosis
|
189 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.030 | 0.667 | 3 | 2012 | 2017 | |||||
Mixed cryoglobulinemia
|
5 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Steatohepatitis
|
75 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Bronchiolitis
|
32 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2012 | 2020 | |||||
Chronic hepatitis C virus genotype 1
|
2 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||
Cirrhosis
|
110 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||
Hodgkin Disease
|
148 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Huntington Disease
|
115 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Icterus
|
17 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2010 | 2019 | |||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 0.500 | 2 | 2012 | 2012 | |||||
Recurrent hepatitis
|
5 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.020 | 1.000 | 2 | 2012 | 2014 | |||||
Acute hepatitis C
|
2 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Acute infectious disease
|
5 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Allergic rhinitis (disorder)
|
176 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1 | 2017 | 2017 | ||||||
Anemia
|
94 | 0.581 | 0.600 | 19 | 39252525 | upstream gene variant | T/G | snv | 0.16 | 0.010 | 1.000 | 1 | 2012 | 2012 |